Najib Allali1,
2, Romain Valabregue2, Malgorzata MarjanskaA3,
4, Pauline Delaveau1, ric Bardinet2, Maritza
Jabourian5, Judith LAREDO5, Philippe Fossati1,
6, Stphane Lehricy2, 7
1USR
3246, CNRS, Paris, le-de-France, France; 2Centre de Neuroimagerie
de Recherche - CENIR, Institut du Cerveau et de la Moelle pinire - ICM,
Paris, le-de-France, France; 3Center for Magnetic Resonance
Research, University of Minnesota, Minneapolis, MN, United States; 4Department
of Radiology, University of Minnesota, Minneapolis, MN, United States; 5Institut
de Recherches Internationales Servier - IRIS, Courbevoie, le-de-France,
France; 6Psychiatry, APHP - GH Piti Salptrire, Paris,
le-de-France, France; 7UMR-S975 ; Inserm, U975 ; CNRS, UMR 7225,
Paris, France, CRICM, Universit Pierre et Marie Curie, Paris, le-de-France,
France
In this study, we sought to identify spectroscopic correlates of depressive state and of response to Agomelatine, a new antidepressant with melatonin agonist and 5-HT2C antagonist properties.